BioAtla (BCAB) Operating Expenses (2020 - 2026)

BioAtla's Operating Expenses history runs 7 years deep, the most recent figure standing at $9.3 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 47.16% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was $53.0 million, a 32.14% decrease from a year earlier, with the FY2025 full-year figure at $61.3 million, down 27.83% from the prior year.
• Operating Expenses eased to $9.3 million in Q1 2026 per BCAB's latest filing, from $11.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $37.2 million in Q2 2023 and bottomed at $9.3 million in Q1 2026.
• The 5-year median for Operating Expenses is $24.3 million (2022), against an average of $23.1 million.
• Across the five-year window, Operating Expenses jumped 33.77% in 2023 and slumped 47.16% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $28.6 million in 2022, then slipped by 0.08% to $28.5 million in 2023, then tumbled by 43.08% to $16.2 million in 2024, then plunged by 30.71% to $11.3 million in 2025, then decreased by 17.3% to $9.3 million in 2026.
• Per Business Quant, the three latest BCAB Operating Expenses figures stand at $9.3 million (Q1 2026), $11.3 million (Q4 2025), and $13.8 million (Q3 2025).